Alcon/Novartis launches Ngenuity 3D Visualization System, a platform for Digitally Assisted Vitreoretinal Surgery.
Alcon, the global leader in eye care and a division of Novartis, launches the Ngenuity 3D Visualization System, a platform for Digitally Assisted Vitreoretinal Surgery (DAVS). The system is designed to enhance visualization of the back of the eye for improved surgeon experience. Alcon is launching the system in collaboration with TrueVision 3D Surgical, a California-based company specializing in digital 3D visualization and guidance for microsurgery.
The Ngenuity 3D Visualization System allows retinal surgeons to operate looking at a high definition 3D screen, instead of bending their necks to look through the eye-piece of a microscope. Traditional vitrectomy surgeries range from 30 minutes to over three hours in length to complete. This microscope-free design is engineered to improve surgeons' posture and may reduce fatigue.
Comment:The device is pending CE Mark and is expected to be available in the United States and specific countries within Europe as of September 15, 2016, and is expected to be available in Japan in December of this year. Other countries are expected to launch the Ngenuity 3D Visualization System over the course of 2017.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins